Skip to main content

Advertisement

Log in

The Role of Exercise on Platelet Aggregation in Patients with Stable Coronary Artery Disease: Exercise Induces Aspirin Resistant Platelet Activation

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Objectives: The aim of our study was to determine the relation between exercise stress test and aspirin resistance in patients with stable coronary artery disease.

Background: Clinically aspirin resistance is defined as having thrombotic and embolic cardiovascular events despite regular aspirin therapy.

Methods: We studied platelet functions of 62 patients with stable coronary artery disease and 20 subjects with normal coronary arteries by Platelet Function Analyzer (PFA-100, Dade Behring, Germany) at rest and after exertion with collagen and/or epinephrine (Col/Epi) and collagen and/or ADP cartridges. Closure time (CT) < 186 seconds was defined as aspirin resistance with Col/Epi cartridges of PFA-100. Symptom limited treadmill stress test (protocol of Bruce) was performed with Oxford Streslink TD-1 system.

Results: 8 (12.9%) patients were aspirin resistant by PFA-100 (CT < 186s despite regular aspirin therapy) at rest. At the first minute of the recovery period of exercise stress test 14 (22.5%) patients were aspirin resistant by PFA-100. CTs with Col/ADP were respectively 89 ± 6 s (83–100s) and 89 ± 5 s (82–104s) at rest and after exercise (p = 0.107). 20.3% (11/54) of patients known as in vitro aspirin sensitives at rest had shorter CTs and 11.1% (6/54) had aspirin resistance after exercise (p = 0.004). There was no statistically significiant difference in platelet functions in the control group after exertion.

Conclusion: We conclude that 11.1% of in vitro aspirin sensitive subjects at rest had aspirin resistance after exercise by PFA-100. In some individuals, exercise induced platelet activation is aspirin insensitive at usual antiplatelet doses. We need further clinical trials to optimize antiplatelet therapy in patients with coronary artery disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ridker PM, Manson JE, et al. The effect of chronic platelet inhibition with low dose aspirin on atherosclerotic progression and acute thrombosis: Clinical evidence from Physicians Health Study. Am Heart J 1991;122:1588–1592.

    Article  PubMed  Google Scholar 

  2. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81–106.

    Google Scholar 

  3. Wallén NH, Ladjevardi M, Albert J, et al. Influence of different anticoagulants on platelet aggregation in whole blood: A comparison between citrate, low molecular mass heparin and hirudin. Thromb Research 1997;87:151–157.

    Article  Google Scholar 

  4. Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88(3):230–235.

    Article  PubMed  Google Scholar 

  5. Patricia A Gum, Kandice Kottke-Marchant, Patricia A.~Welsh, et al. A Prospective, Blinded Determination of the Natural History of Aspirin Resistance Among Stable Patients With Cardiovascular Disease. J Am Coll Cardiol 2003;41:961–965.

    Article  PubMed  Google Scholar 

  6. Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina pectoris. Circulation 1997;96:1109–1116.

    PubMed  Google Scholar 

  7. Cipollone F, Prontera C, Pini B, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 2001;104:921–927.

    PubMed  Google Scholar 

  8. Belton O, Byrne D, Kearney D, et al. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000;102:840–845.

    PubMed  Google Scholar 

  9. Davis JW, Hartman CR, Lewis HD, et al. Cigarette smoking-induced enhancement of platelet function: Lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 1985;105:479–483.

    PubMed  Google Scholar 

  10. Santos MT, Valles J, Marcus AJ, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 1991;87:572–580.

    Google Scholar 

  11. Kawasaki T, Ozeki Y, Igawa T, et al. Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke 2000;31:591–595.

    PubMed  Google Scholar 

  12. Samani NJ, Lodwick D. Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res 1997;33(3):693–697.

    Article  PubMed  Google Scholar 

  13. Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000;101(9):1013–1018.

    PubMed  Google Scholar 

  14. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;25;334(17):1090–1094.

    Google Scholar 

  15. Maalej N, Folts JD. Increased shear stress overcomes the anti-thrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries. Circulation 1996;93:1201–1205.

    PubMed  Google Scholar 

  16. Patrono C, FitzGerald GA. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997;17:2309–2315.

    PubMed  Google Scholar 

  17. McKee SA, Sane DC, Deliargyris EN. Aspirin resistance in cardiovascular disease: A review of prevalence, mechanisms, and clinical significance. Thromb Haemost 2002;88(5):711–715.

    PubMed  Google Scholar 

  18. Wallén NH, Held C, Rehnqvist N, et al. Effects of mental and phyciasl stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J 1997;18:807–815.

    PubMed  Google Scholar 

  19. Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951–1957.

    PubMed  Google Scholar 

  20. Mammen EF, Alsbameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100® system. Semin Thromb Hemost 1995;21(suppl.2):113–121.

    PubMed  Google Scholar 

  21. Bock M, De Haan J, Beck KH, et al. Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: Effect of gender, smoking, and oral contraceptives. Br J Haematol 1999;106(4):898–904.

    Article  PubMed  Google Scholar 

  22. Jilma B. Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001;138(3):152–163.

    Article  PubMed  Google Scholar 

  23. Favaloro EJ. Clinical application of the PFA-100(R). Curr Opin Hematol 2002;9(5):407–415.

    Article  PubMed  Google Scholar 

  24. Wang JS, Jen CJ, Kung HC, et al. Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation 1994;90:2877–2885.

    PubMed  Google Scholar 

  25. El-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996;22:282–298.

    PubMed  Google Scholar 

  26. Villich SN, Lewis M, Löwel H, et al. Physical exertion as trigger of acute myocardial infarction. N Engl J Med 1993;329:1684–1690.

    Article  PubMed  Google Scholar 

  27. Tokuue J, Hayashi J, Hata Y, et al. Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina. Thromb Haemost 1996;75:833–837.

    PubMed  Google Scholar 

  28. Jong-Shyan Wang. Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willebrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets. Eur J Appl Physiol 2004;91:741–747.

    Article  PubMed  Google Scholar 

  29. Andreotti F, Lanza G, Sciahbasi A, et al. Low-grade exercise enhances platelet aggregability in patients with obstructive coronary disease independently of myocardial ischemia. Am J Cardiol 2001;87:16–20.

    Article  PubMed  Google Scholar 

  30. Hurlen M, Seljeflot I, Arnesen H. Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by Aspirin. Thrombosis Research 2000;99:487–494.

    Article  PubMed  Google Scholar 

  31. Christiaens L, Macchi L, Herpin D, et al. Resistance to aspirin in vitrro at rest and during exercise in patients with angiographically proven coronary artery disease. Thrombosis Research 2003;108:115–119.

    Article  Google Scholar 

  32. C. Di Massimo, P. Scarpelli, M.G. Tozzi-Ciancarelli. Possible involvement of oxidative stress in exercise-mediated platelet activation. Clinical Hemorheology and Microcirculation 2004;30:313–336.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Burak Pamukcu.

Additional information

The main supporter of the study was Turkish Society of Cardiology (Istanbul, Turkey). The society is a non-profit association and a member of the European Society of Cardiology. The PFA-100 device and test cartridges are bought with the grant of this non-profit association.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pamukcu, B., Oflaz, H., Acar, R.D. et al. The Role of Exercise on Platelet Aggregation in Patients with Stable Coronary Artery Disease: Exercise Induces Aspirin Resistant Platelet Activation. J Thromb Thrombolysis 20, 17–22 (2005). https://doi.org/10.1007/s11239-005-2318-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-005-2318-1

Key Words

Navigation